MedTrace Logo

Low-level Laser Therapy on Temporomandibular Disorder

NCT01846000 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2013-05-03

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of low-level laser on pain, occlusal contacts, mandibular movements and electromyography activity in the masseter and temporal muscles in adolescents with TMD.

Conditions

  • Temporomandibular Disorder

Interventions

PROCEDURE

low-level laser treatment

A gallium-aluminum-arsenide laser will be employed for the LLLT and placebo treatment. The device will be calibrated with a wavelength of 780 nm, energy density of 25 J/cm2, power of 50 mW and power density of 1.25 W/cm2. Exposure time will be 20 seconds per point, resulting in a total energy of 1 J per point. The spot application method will be used in contact with the skin and with a conventional tip, covering an area of 0.04 cm2.

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    collaborator OTHER_GOV

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

    collaborator OTHER_GOV

  • University of Nove de Julho

    lead OTHER

Principal Investigators

  • Camila HL Godoy · University of Nove de Julho

  • Lara J Motta · University of Nove de Julho

  • Daniela A Biasotto-Gonzalez · University of Nove de Julho

  • Fabiano Politti · University of Nove de Julho

  • Raquel A Mesquita-Ferrari · University of Nove de Julho

  • Kristianne PS Fernandes · University of Nove de Julho

  • Sandra K Bussadori · University of Nove de Julho

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-10-31
Completion
2013-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01846000 on ClinicalTrials.gov